| Articles |
|
Contemporary requirements for organization ofclinical trials in health care system
Vartapetova N.V., Karpushkina A.V., Vartepova N.V., Karpushkina A.V.
Osteoporosis and Bone Diseases. 2011;14(1):3-7
|
|
(Rus)
|
|
Inhibition of activity of collagen degradation in cartilage of patients with osteoarthrosis byactivation of glycolysis
Chetina E.V., Chetina E.V.
Osteoporosis and Bone Diseases. 2011;14(1):8-12
|
|
(Rus)
|
|
Analysis of epidemiology of osteoporotic fracturesusing data from primary care physicians
Gladkova E.N., Khodyrev V.N., Lesnyak O.M., Gladkova E.N., Chodyrev V.N., Lesnyak O.M.
Osteoporosis and Bone Diseases. 2011;14(1):14-18
|
|
(Rus)
|
|
Interrelation of bone mineral density with kneeosteoarthrosis
Zaytseva E.M., Smirnov A.V., Alekseeva L.I., Zaitseva E.M., Smirnov A.V., Alekseeva L.I.
Osteoporosis and Bone Diseases. 2011;14(1):19-20
|
|
(Rus)
|
|
Obesity and osteoporosis
Shishkova V.N., Shishkova V.N.
Osteoporosis and Bone Diseases. 2011;14(1):21-26
|
|
(Rus)
|
|
Massive osteolysis - gorham-stout syndrome
Otteva E.N., Kocherova T.Y., Shepichev E.V., Otteva E.N., Kocherova T.Y., Shepichev E.V.
Osteoporosis and Bone Diseases. 2011;14(1):27-32
|
|
(Rus)
|
|
The influence of surgical menopause oncardiovascular and osteoporosis risk factors(clinical observations)
Maychuk E.Y., Voevodina I.V., Moiseenko S.V., Mitrokhina T.V., Skripnikova I.A., Sapunova D.A., Maichuk E.Y., Voevodina I.V., Moiseenko S.V., Mitrokhina T.V., Skripnikova I.A., Sapunova D.A.
Osteoporosis and Bone Diseases. 2011;14(1):33-36
|
|
(Rus)
|
|
The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft.
Black D., Reid I.R., Cauley J.A., Boonen S., Cosman F., Leung P.C., Lakatos P., Man Z., Cummings S.R., Hue T.F., Ruzycky M.E., Martinez R., Su G., Bucci-Rechtweg C., Eastell R.
Osteoporosis and Bone Diseases. 2011;14(1):37-37
|
|
(Rus)
|
|
Long treatment with strontium ranelate of womenwith postmenopausal osteoporosis: 10-year results
Reginster J.Y., Kaufman J.M., Goemaere S., Benhamou C.L., Balogh A., Albanese C., Badurski J., Roux C.
Osteoporosis and Bone Diseases. 2011;14(1):38-38
|
|
(Rus)
|
|
The influence of denosumab on one mineral densityand biochemical markers of bone remodeling: results of 6-year phase ii trial
Miller P.D., Wagman R.B., Peacock M., Lewiecki E.M., Bolognese M.A., Weinstein R.L., Ding B., San Martin J., McClung M.R.
Osteoporosis and Bone Diseases. 2011;14(1):39-39
|
|
(Rus)
|
|
Five-year denosumab treatment of postmenopausalwomen with osteoporosis: results of the first twoyears of the freedom trial extension.
Papapoulos S., Man Z., Mellstrom D., Radominski S., Reginster J., Resch H., Roman J., Roux S., Cummings S., Bone H., Chapurlar R., Brandi M., Brown J., Czerwinski E., Daizadeh N., Grauer A., Krieg M., Libanati S.
Osteoporosis and Bone Diseases. 2011;14(1):40-40
|
|
(Rus)
|
|
For 70-year anniversary of academician of ras and rams I.I. Dedov
- -.
Osteoporosis and Bone Diseases. 2011;14(1):41-41
|
|
(Rus)
|
|
For 80-year anniversary of professor L.I. Benevolenskaya
- -.
Osteoporosis and Bone Diseases. 2011;14(1):42-42
|
|
(Rus)
|
|
Manuscript preparation guidelines for authors
- -.
Osteoporosis and Bone Diseases. 2011;14(1):43-44
|
|
(Rus)
|
